Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3A | Q14432 | 3/20 | 0.52 |
| ▸ | PDE4D | Q08499 | 1/20 | 0.52 |
| ▸ | SLC29A1 | Q99808 | 1/20 | 0.52 |
| ▸ | LMNA | P02545 | 5/20 | 0.46 |
| ▸ | MTOR | P42345 | 2/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | MDM2 | Q00987 | 1/20 | 0.46 |
| ▸ | NCOA1 | Q15788 | 1/20 | 0.46 |
| ▸ | NCOA3 | Q9Y6Q9 | 1/20 | 0.46 |
| ▸ | CACNA1F | O60840 | 2/20 | 0.40 |
| ▸ | ALB | P02768 | 2/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | CACNA1D | Q01668 | 2/20 | 0.40 |
| ▸ | CACNA1S | Q13698 | 2/20 | 0.40 |
| ▸ | CACNA1C | Q13936 | 2/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | DNMT1 | P26358 | 2/20 | 0.35 |
| ▸ | ADRB1 | P08588 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3424602 | 0.84 | PDE3A (0.47) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL1939478 | 0.84 | PDE3A (0.47) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL28379714 | 0.84 | PDE3A (0.47) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL31448322 | 0.84 | POLB (0.46) | PDE3APDE4DSLC29A1POLBPOLA1 | |
| SCHEMBL3489429 | 0.84 | PDE3A (0.47) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL7794942 | 0.83 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL4971926 | 0.83 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL3449198 | 0.83 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL51650 | 0.83 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR | |
| SCHEMBL992472 | 0.83 | PDE3A (0.46) | PDE3APDE4DSLC29A1LMNAMTOR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 175 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117070491-B | Purine nucleoside phosphorylase mutant and preparation method of 2' -fluoronucleoside | 吉林凯莱英制药有限公司 | 2024-01-19 | — | — | CN | claimed |
| CN-117106744-A | Pyrimidine nucleoside phosphorylase mutant and preparation method of 2' -fluoronucleoside | 吉林凯莱英制药有限公司 | 2023-11-24 | — | — | CN | claimed |
| CN-117070491-A | Purine nucleoside phosphorylase mutant and preparation method of 2' -fluoronucleoside | 吉林凯莱英制药有限公司 | 2023-11-17 | — | — | CN | claimed |
| CN-110234319-A | The composition and its application method of benzamide and reactive compound | 转化药物开发有限责任公司 | 2019-09-13 | — | — | CN | claimed |
| CN-105874059-A | Improved methods for producing mammalian pluripotent stem cell-derived endodermal cells | 宝生物欧洲公司 | 2016-08-17 | — | — | CN | claimed |
| CN-101868254-B | Positron emission tomography probes for imaging immune activation and selected cancers | UNIV CALIFORNIA | 2013-08-21 | — | — | CN | claimed |
| CN-101868254-A | The positron emission transaxial tomography probe that immune activation and selected cancers imaging are used | UNIV CALIFORNIA | 2010-10-20 | — | — | CN | claimed |
| CN-101312737-A | Parapoxviruses in combination with traditional cytotoxic chemotherapeutic agents as biochemical treatments for cancer | AICURIS GMBH & CO KG (DE) | 2008-11-26 | — | — | CN | claimed |
| EP-1156827-A2 | TREATMENT OF NEOPLASTIC DISEASES BY RADIATION | Halogenetics, Inc. (US) | 2001-11-28 | — | — | EP | claimed |
| WO-2000051639-A9 | TREATMENT OF NEOPLASTIC DISEASES BY RADIATION | HALOGENETICS INC (US) | 2001-10-25 | — | — | WO | claimed |
| WO-2000051639-A2 | TREATMENT OF NEOPLASTIC DISEASES BY RADIATION | HALOGENETICS, INC. (US) | 2000-09-08 | — | — | WO | claimed |
| EP-0504279-B1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | CHEMGEN CORP (US) | 1997-07-09 | — | — | EP | claimed |
| US-5213972-A | Production of thymidine and deoxyuridine, intermediates for AZT | CHEMGEN CORPORATION (US) | 1993-05-25 | — | — | US | claimed |
| EP-0504279-A4 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | — | 1993-02-17 | — | — | EP | claimed |
| EP-0504279-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES. | CHEMGEN CORP (US) | 1992-09-23 | — | — | EP | claimed |
| WO-1991009130-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | CHEMGEN CORPORATION (US) | 1991-06-27 | — | — | WO | claimed |
| EP-0287128-A1 | Antitumor agent | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1988-10-19 | — | — | EP | claimed |
| CN-113396219-B | Purification of mRNA by tangential flow filtration | ETHRIS GMBH (DE) | 2026-05-26 | — | — | CN | disclosed |
| WO-1991009130-A1 | FERMENTATION PROCESS FOR THE PRODUCTION OF PYRIMIDINE DEOXYRIBONUCLEOSIDES | CHEMGEN CORPORATION (US) | 1991-06-27 | — | — | WO | disclosed |
| EP-0287128-A1 | Antitumor agent | RESEARCH CORPORATION TECHNOLOGIES, INC. (US) | 1988-10-19 | — | — | EP | disclosed |